National Board of Health, Copenhagen, Denmark.
J Health Serv Res Policy. 2011 Jul;16 Suppl 2:6-15. doi: 10.1258/jhsrp.2011.011050.
To provide an overview of health services research related to health technology assessment (HTA) and to identify research priorities from a European perspective.
Several methods were used: systematic review of articles indexed with the MeSH term 'technology assessment' in PubMed from February 1999-2009; online survey among experts; and conference workshop discussions.
Research activity in HTA varies considerably across Europe. The research was categorised into six areas: (1) the breadth of analysis in HTA (such as economic, organizational and social aspects); (2) HTA products developed to meet the needs of policy-makers (such as horizon scanning, mini-HTA, and core HTA); (3) handling life-cycle perspectives in relation to technologies; (4) topics that challenge existing methods and for which HTA should be developed to address the themes more comprehensively (such as public health interventions and organizational interventions); (5) development of HTA capacity and programmes; and (6) links between policy and HTA. An online survey showed that the three areas that were given priority were the relationship between HTA and policy-making (71%), the impact of HTA (62%) and incorporating patient aspects in HTA (50%). Policy-makers highlighted HTA and innovation processes as their main research priority (42%). Areas that the systematic review identified as future priorities include issues within the six existing research areas such as disinvestment, developing evidence for new technologies, assessing the wider effects of technology use, and determining how HTA affects decision-making. In addition, relative effectiveness and individualized treatments are areas of growing interest.
The research priorities identified are important for obtaining high quality and cost-effective health care in Europe. Managing the introduction, use and phasing out of technologies challenges health services throughout Europe, and these processes need to be improved to successfully manage future more general challenges. An ageing population and a diminishing workforce both require strong efforts to ensure effective and well-organized use of human resources and technologies. Furthermore, Europe needs to focus on innovation. This is closely linked to use of technologies and calls for future research.
从欧洲角度概述与卫生技术评估(HTA)相关的卫生服务研究,并确定研究重点。
采用了多种方法:系统检索 1999 年 2 月至 2009 年在 PubMed 中以“技术评估”MeSH 术语索引的文章;在线调查专家;以及会议研讨会讨论。
HTA 的研究活动在欧洲各地差异很大。研究分为六个领域:(1)HTA 分析的广度(例如经济、组织和社会方面);(2)为满足决策者需求而开发的 HTA 产品(如远景扫描、迷你 HTA 和核心 HTA);(3)在与技术相关的生命周期方面进行处理;(4)挑战现有方法且需要开发 HTA 以更全面地解决主题的主题(如公共卫生干预和组织干预);(5)HTA 能力和计划的发展;以及(6)政策与 HTA 之间的联系。在线调查显示,被优先考虑的三个领域是 HTA 与决策之间的关系(71%)、HTA 的影响(62%)以及将患者方面纳入 HTA(50%)。政策制定者强调 HTA 和创新过程是他们的主要研究重点(42%)。系统评价确定的未来优先事项包括现有六个研究领域内的问题,例如投资撤资、为新技术开发证据、评估技术使用的更广泛影响以及确定 HTA 如何影响决策。此外,相对有效性和个体化治疗是日益关注的领域。
确定的研究重点对于在欧洲获得高质量和具有成本效益的医疗保健至关重要。管理技术的引入、使用和逐步淘汰对整个欧洲的卫生服务构成挑战,需要改进这些流程,以成功应对未来更广泛的挑战。人口老龄化和劳动力减少都需要大力努力,以确保有效和组织良好地利用人力资源和技术。此外,欧洲需要专注于创新。这与技术的使用密切相关,并需要进行未来的研究。